These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22866168)

  • 1. Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition.
    Lu Y; Zhang X; Zhang J
    J Cancer; 2012; 3():333-44. PubMed ID: 22866168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.
    Li L; Lu Y
    J Cancer; 2010 Sep; 1():126-35. PubMed ID: 20922054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.
    Zhang J; Lu A; Beech D; Jiang B; Lu Y
    Cancer Ther; 2007; 5():273-286. PubMed ID: 18548129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Analysis of the p16 Gene and Protein in Canine Lymphoma Cells and Their Correlation with pRb Phosphorylation.
    Maylina L; Kambayashi S; Baba K; Okuda M
    Vet Sci; 2022 Jul; 9(8):. PubMed ID: 36006308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
    Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
    Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis.
    Capparelli C; Chiavarina B; Whitaker-Menezes D; Pestell TG; Pestell RG; Hulit J; Andò S; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Oct; 11(19):3599-610. PubMed ID: 22935696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.
    Matsumura K; Nakata S; Taniguchi K; Ii H; Ashihara E; Kageyama S; Kawauchi A; Yoshiki T
    BMC Cancer; 2016 Sep; 16(1):748. PubMed ID: 27658708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16
    Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral p16/CDKN2 gene transfer to malignant glioma: role of p16 in growth, invasion, and senescence.
    Kim SK; Wang KC; Cho BK; Lim SY; Kim YY; Oh CW; Chung YN; Kim CY; Lee CT; Kim HJ
    Oncol Rep; 2003; 10(5):1121-6. PubMed ID: 12883667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
    Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
    J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.
    Simon M; Simon C; Köster G; Hans VH; Schramm J
    J Neurooncol; 2002 Oct; 60(1):1-12. PubMed ID: 12416540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16(MTS-1/CDKN2/INK4a) in cancer progression.
    Rocco JW; Sidransky D
    Exp Cell Res; 2001 Mar; 264(1):42-55. PubMed ID: 11237522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus p16 gene therapy for prostate cancer.
    Allay JA; Steiner MS; Zhang Y; Reed CP; Cockroft J; Lu Y
    World J Urol; 2000 Apr; 18(2):111-20. PubMed ID: 10854145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence of human fibroblasts induced by oncogenic Raf.
    Zhu J; Woods D; McMahon M; Bishop JM
    Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
    Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.
    Al-Ansari MM; Hendrayani SF; Tulbah A; Al-Tweigeri T; Shehata AI; Aboussekhra A
    Neoplasia; 2012 Dec; 14(12):1269-77. PubMed ID: 23308058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.
    Hu Z; Zhang D; Hao J; Tian K; Wang W; Lou H; Yuan H
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):397-407. PubMed ID: 24322375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
    Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
    Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.